Index by Author

September 1989; 12 (8)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

B

  1. Bailey, C J

    • Traditional plant medicines as treatments for diabetes. Diabetes Care September 1989 12:553-564; doi:10.2337/diacare.12.8.553

  2. Bernstein, R K

    • More news of cloudy regular insulin. Diabetes Care September 1989 12:598-599

  3. Boehm, R

    • Breast augmentation: a new therapeutic use for insulin? Diabetes Care September 1989 12:597-598

  4. Borzi, V

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582

C

  1. Church, L B

    • Patient-oriented criteria for evaluation of self-monitoring of blood glucose devices. Diabetes Care September 1989 12:594-595

D

  1. Daneman, D

    • Relationship of insulin autoantibodies to presentation and early course of IDDM in children. Diabetes Care September 1989 12:517-523; doi:10.2337/diacare.12.8.517

  2. Day, C

    • Traditional plant medicines as treatments for diabetes. Diabetes Care September 1989 12:553-564; doi:10.2337/diacare.12.8.553

E

  1. Eadington, D W

    • Accident risk of the diabetic driver. Diabetes Care September 1989 12:597

F

  1. Frier, B M

    • Accident risk of the diabetic driver. Diabetes Care September 1989 12:597

  2. Frittitta, L

    • Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care September 1989 12:585-587; doi:10.2337/diacare.12.8.585

G

  1. Gannon, M C

    • Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care September 1989 12:544-552; doi:10.2337/diacare.12.8.544

  2. Glauber, H S

    • Patient-oriented criteria for evaluation of self-monitoring of blood glucose devices. Diabetes Care September 1989 12:594-595

  3. Graner, J L

    • The nonphysician endocrinologist. Has Osler's nightmare come true? Diabetes Care September 1989 12:598

H

  1. Haffner, S M

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

  2. Harman-Boehm, I

    • Breast augmentation: a new therapeutic use for insulin? Diabetes Care September 1989 12:597-598

  3. Hazuda, H P

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

  4. Henry, D N

    • Pediatric primary care for children with type I diabetes. Diabetes Care September 1989 12:595-596

  5. Hosojima, H

    • Urinary excretion of angiotensin-converting enzyme in NIDDM patients with nephropathy. Diabetes Care September 1989 12:580-582; doi:10.2337/diacare.12.8.580

  6. Huxtable, K

    • Adjustment to diabetes mellitus in preschoolers and their mothers. Diabetes Care September 1989 12:524-529; doi:10.2337/diacare.12.8.524

I

  1. Italia, S

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582

K

  1. Klauser, R M

    • Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care September 1989 12:537-543; doi:10.2337/diacare.12.8.537

  2. Klein, R

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

  3. Kozlowski, M K

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

L

  1. Linscheid, T R

    • Adjustment to diabetes mellitus in preschoolers and their mothers. Diabetes Care September 1989 12:524-529; doi:10.2337/diacare.12.8.524

M

  1. Mazzarino, S

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582

  2. McGill, M J

    • Single-visit screening of diabetic complications. Diabetes Care September 1989 12:599-600

  3. Mitchell, B D

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

  4. Miyauchi, E

    • Urinary excretion of angiotensin-converting enzyme in NIDDM patients with nephropathy. Diabetes Care September 1989 12:580-582; doi:10.2337/diacare.12.8.580

  5. Morimoto, S

    • Urinary excretion of angiotensin-converting enzyme in NIDDM patients with nephropathy. Diabetes Care September 1989 12:580-582; doi:10.2337/diacare.12.8.580

N

  1. Naylor, C D

    • Diagnosing gestational diabetes mellitus. Is the gold standard valid? Diabetes Care September 1989 12:565-572; doi:10.2337/diacare.12.8.565

  2. Neil, B J

    • Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care September 1989 12:544-552; doi:10.2337/diacare.12.8.544

  3. Nuttall, F Q

    • Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care September 1989 12:544-552; doi:10.2337/diacare.12.8.544

P

  1. Patterson, J K

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

  2. Plehwe, W E

    • Single-visit screening of diabetic complications. Diabetes Care September 1989 12:599-600

  3. Prager, R J

    • Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care September 1989 12:537-543; doi:10.2337/diacare.12.8.537

  4. Pugh, J A

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

S

  1. Schernthaner, G

    • Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care September 1989 12:537-543; doi:10.2337/diacare.12.8.537

  2. Schnack, C

    • Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care September 1989 12:537-543; doi:10.2337/diacare.12.8.537

  3. Schneider, B G

    • Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care September 1989 12:537-543; doi:10.2337/diacare.12.8.537

  4. Seaquist, E R

    • Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care September 1989 12:544-552; doi:10.2337/diacare.12.8.544

  5. Sochett, E

    • Relationship of insulin autoantibodies to presentation and early course of IDDM in children. Diabetes Care September 1989 12:517-523; doi:10.2337/diacare.12.8.517

  6. Squatrito, S

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582
    • Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care September 1989 12:585-587; doi:10.2337/diacare.12.8.585

  7. Stern, M P

    • Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care September 1989 12:530-536; doi:10.2337/diacare.12.8.530

T

  1. Tomaselli, L

    • Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care September 1989 12:585-587; doi:10.2337/diacare.12.8.585

  2. Tribulato, A

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582

  3. Trischitta, V

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582
    • Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care September 1989 12:585-587; doi:10.2337/diacare.12.8.585

  4. Turtle, J R

    • Single-visit screening of diabetic complications. Diabetes Care September 1989 12:599-600

V

  1. Vigneri, R

    • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care September 1989 12:582-585; doi:10.2337/diacare.12.8.582
    • Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care September 1989 12:585-587; doi:10.2337/diacare.12.8.585

  2. Vinci, C

    • Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care September 1989 12:585-587; doi:10.2337/diacare.12.8.585

W

  1. Wayne, W

    • Adjustment to diabetes mellitus in preschoolers and their mothers. Diabetes Care September 1989 12:524-529; doi:10.2337/diacare.12.8.524

  2. Westphal, S A

    • Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care September 1989 12:544-552; doi:10.2337/diacare.12.8.544

  3. Willey, K A

    • Single-visit screening of diabetic complications. Diabetes Care September 1989 12:599-600

  4. Winkler, J

    • Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care September 1989 12:537-543; doi:10.2337/diacare.12.8.537

  5. Wolever, T M

    • How important is prediction of glycemic responses? Diabetes Care September 1989 12:591-593

  6. Wysocki, T

    • Adjustment to diabetes mellitus in preschoolers and their mothers. Diabetes Care September 1989 12:524-529; doi:10.2337/diacare.12.8.524

Y

  1. Yue, D K

    • Single-visit screening of diabetic complications. Diabetes Care September 1989 12:599-600

Current Issue

  1. December 2009, 32 (12)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care